gsk 1018921
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2007 (NCT00527020)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glycine transporter 1INHIBITOR
SLC6A9 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk1018921
- gsk1018921
- gsk 1018921
- gsk-1018921
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00929370 | Phase 1 | Jul 1, 2008 | GlaxoSmithKline |
| NCT00945503 | Phase 1 | May 1, 2008 | GlaxoSmithKline |
| NCT00527020 | Phase 1 | Aug 1, 2007 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 3 | 3 | 1 | 2007 |
1 organizations
Page 1 / 1